Keywords
Last Name

Linda E. Hyman, PhD

TitleAssociate Provost
InstitutionBoston University School of Medicine, Division of Graduate Medical Sciences
Address72 E. Concord St Instructional (L)
Boston MA 02118
Phone(617) 638-5138
ORCID ORCID Icon0000-0002-2511-2928
Other Positions
TitleProfessor
InstitutionBoston University School of Medicine
DepartmentMicrobiology

TitleGraduate Faculty (Primary Mentor of Grad Students)
InstitutionBoston University School of Medicine, Division of Graduate Medical Sciences

 Research Expertise & Professional Interests
Dr. Linda Hyman assumed the position of Associate Provost for the Division of Graduate Medical Sciences in 2009. She formerly served as Vice Provost for Health Science at Montana State University and Director of the WWAMI Medical Education Program. There, she also acted as Assistant Dean for Regional Affairs at the University of Washington School of Medicine. An accomplished and active scientist with expertise in molecular genetics, Dr. Hyman holds the appointment of Professor of Microbiology at GMS. Dr. Hyman earned her undergraduate degree at the State University of New York at Albany, followed by a master’s and doctoral degree at Brandeis University. She also completed a post-doctoral fellowship at Tufts University School of Medicine. She then began her professional career at Tulane University School of Medicine, where she became a tenured associate professor in 2003. Dr. Hyman’s priorities outside of her role as associate provost and professor include advising and professional development for students and post-docs.

 NIH RePORTER Grants

Yr Title Project-Sub Proj Pubs
2016 BU's BEST 5DP7OD020322-03
2015 BU's BEST 5DP7OD020322-02
2014 BU's BEST 1DP7OD020322-01
2008 Montana Initiative for Maximizing Student Diversity 5R25GM056806-10 3
2007 ADMINISTRATIVE CORE 1P20MD002317-01-9004 7
2007 Consortium for Community-Based Research in Native American Health 1P20MD002317-01 7
2007 Bridging Tribal Colleges to Montana State University 2R25GM063983-05
2007 Montana Initiative for Maximizing Student Diversity 2R25GM056806-09 3
2001 ELONGIN C: FUNCTION AND ROLE IN VHL DISEASE 5R21CA084095-02 2
2000 ELONGIN C: FUNCTION AND ROLE IN VHL DISEASE 1R21CA084095-01 2
Showing the 10 most recent of 12 results. Show All Results

 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Dasgupta S, Symes K, Hyman L. Leading change: curriculum reform in graduate education in the biomedical sciences. Biochem Mol Biol Educ. 2015 Mar-Apr; 43(2):126-32. PMID: 25735833.
    View in: PubMed
  2. Crabbé A, Nielsen-Preiss SM, Woolley CM, Barrila J, Buchanan K, McCracken J, Inglis DO, Searles SC, Nelman-Gonzalez MA, Ott CM, Wilson JW, Pierson DL, Stefanyshyn-Piper HM, Hyman LE, Nickerson CA. Spaceflight enhances cell aggregation and random budding in Candida albicans. PLoS One. 2013; 8(12):e80677. PMID: 24324620.
    View in: PubMed
  3. Searles SC, Woolley CM, Petersen RA, Hyman LE, Nielsen-Preiss SM. Modeled microgravity increases filamentation, biofilm formation, phenotypic switching, and antimicrobial resistance in Candida albicans. Astrobiology. 2011 Oct; 11(8):825-36. PMID: 21936634.
    View in: PubMed
  4. Altenburg SD, Nielsen-Preiss SM, Hyman LE. Increased filamentous growth of Candida albicans in simulated microgravity. Genomics Proteomics Bioinformatics. 2008 Mar; 6(1):42-50. PMID: 18558384.
    View in: PubMed
  5. Purevdorj-Gage B, Orr ME, Stoodley P, Sheehan KB, Hyman LE. The role of FLO11 in Saccharomyces cerevisiae biofilm development in a laboratory based flow-cell system. FEMS Yeast Res. 2007 May; 7(3):372-9. PMID: 17233763.
    View in: PubMed
  6. Sheehan KB, McInnerney K, Purevdorj-Gage B, Altenburg SD, Hyman LE. Yeast genomic expression patterns in response to low-shear modeled microgravity. BMC Genomics. 2007; 8:3. PMID: 17201921.
    View in: PubMed
  7. Purevdorj-Gage B, Sheehan KB, Hyman LE. Effects of low-shear modeled microgravity on cell function, gene expression, and phenotype in Saccharomyces cerevisiae. Appl Environ Microbiol. 2006 Jul; 72(7):4569-75. PMID: 16820445.
    View in: PubMed
  8. Brumlik MJ, Wei S, Finstad K, Nesbit J, Hyman LE, Lacey M, Burow ME, Curiel TJ. Identification of a novel mitogen-activated protein kinase in Toxoplasma gondii. Int J Parasitol. 2004 Oct; 34(11):1245-54. PMID: 15491587.
    View in: PubMed
  9. Johanson K, Hoang T, Sheth M, Hyman LE. GRS1, a yeast tRNA synthetase with a role in mRNA 3' end formation. J Biol Chem. 2003 Sep 19; 278(38):35923-30. PMID: 12855679.
    View in: PubMed
  10. Johanson K, Allen PL, Lewis F, Cubano LA, Hyman LE, Hammond TG. Saccharomyces cerevisiae gene expression changes during rotating wall vessel suspension culture. J Appl Physiol (1985). 2002 Dec; 93(6):2171-80. PMID: 12391061.
    View in: PubMed
  11. Hyman LE, Kwon E, Ghosh S, McGee J, Chachulska AM, Jackson T, Baricos WH. Binding to Elongin C inhibits degradation of interacting proteins in yeast. J Biol Chem. 2002 May 3; 277(18):15586-91. PMID: 11864988.
    View in: PubMed
  12. Jackson T, Kwon E, Chachulska AM, Hyman LE. Novel roles for elongin C in yeast. Biochim Biophys Acta. 2000 Apr 25; 1491(1-3):161-76. PMID: 10760578.
    View in: PubMed
  13. Magrath C, Hyman LE. A mutation in GRS1, a glycyl-tRNA synthetase, affects 3'-end formation in Saccharomyces cerevisiae. Genetics. 1999 May; 152(1):129-41. PMID: 10224248.
    View in: PubMed
  14. Magrath C, Lund K, Miller CA, Hyman LE. Overlapping 3'-end formation signals and ARS elements: tightly linked but functionally separable. Gene. 1998 Nov 5; 222(1):69-75. PMID: 9813245.
    View in: PubMed
  15. Chen S, Hyman LE. A specific RNA-protein interaction at yeast polyadenylation efficiency elements. Nucleic Acids Res. 1998 Nov 1; 26(21):4965-74. PMID: 9776761.
    View in: PubMed
  16. Miller CA, Martinat MA, Hyman LE. Assessment of aryl hydrocarbon receptor complex interactions using pBEVY plasmids: expressionvectors with bi-directional promoters for use in Saccharomyces cerevisiae. Nucleic Acids Res. 1998 Aug 1; 26(15):3577-83. PMID: 9671822.
    View in: PubMed
  17. Chen S, Reger R, Miller C, Hyman LE. Transcriptional terminators of RNA polymerase II are associated with yeast replication origins. Nucleic Acids Res. 1996 Aug 1; 24(15):2885-93. PMID: 8760869.
    View in: PubMed
  18. Hyman LE, Moore CL. Termination and pausing of RNA polymerase II downstream of yeast polyadenylation sites. Mol Cell Biol. 1993 Sep; 13(9):5159-67. PMID: 8355675.
    View in: PubMed
  19. Hyman LE, Seiler SH, Whoriskey J, Moore CL. Point mutations upstream of the yeast ADH2 poly(A) site significantly reduce the efficiency of 3'-end formation. Mol Cell Biol. 1991 Apr; 11(4):2004-12. PMID: 2005893.
    View in: PubMed
  20. Hyman LE, Wormington WM. Translational inactivation of ribosomal protein mRNAs during Xenopus oocyte maturation. Genes Dev. 1988 May; 2(5):598-605. PMID: 2454870.
    View in: PubMed
  21. Baum EZ, Hyman LE, Wormington WM. Post-translational control of ribosomal protein L1 accumulation in Xenopus oocytes. Dev Biol. 1988 Mar; 126(1):141-9. PMID: 3342930.
    View in: PubMed
  22. Schafer U, Golden L, Hyman LE, Colot HV, Rosbash M. Some somatic sequences are absent or exceedingly rare in Xenopus oocyte RNA. Dev Biol. 1982 Nov; 94(1):87-92. PMID: 6185378.
    View in: PubMed
Linda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_